Form 4: Rigel CFO Exercises Stock Options, Boosts Holdings

Rigel Pharmaceuticals' EVP & CFO, Dean L. Schorno, exercised multiple employee stock options on December 22, 2025, increasing his direct beneficial ownership of common stock.

Summary

• Dean L. Schorno, Executive Vice President and Chief Financial Officer of Rigel Pharmaceuticals, Inc. (RIGL), reported transactions involving the exercise of employee stock options.
• On December 22, 2025, Schorno acquired 1,987 shares of common stock at an exercise price of $20 per share.
• Concurrently, he acquired an additional 2,846 shares of common stock at an exercise price of $24.2 per share.
• A further 1,667 shares of common stock were acquired at an exercise price of $18.7 per share on the same date.
• All reported share numbers and prices have been adjusted to reflect a one-for-ten reverse stock split effective June 27, 2024.
• Following these transactions, Schorno's direct beneficial ownership of common stock increased to 64,235 shares, which includes 500 shares acquired under the Issuer's stock purchase plan.
• The exercised options had vesting commencement dates of January 1, 2019, January 1, 2020, and January 1, 2023, with shares vesting in equal monthly installments over four years, contingent on continuous service.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as an executive is increasing their direct ownership in the company, which can be interpreted as a sign of confidence. However, it is a routine transaction (option exercise) and not indicative of extraordinary news.

Positives

• Increased direct beneficial ownership by a key executive, Dean L. Schorno, signals confidence in the company's future prospects.
• The exercise of options indicates a long-term commitment from management, as these options were part of multi-year vesting schedules.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing details a routine insider transaction (option exercise) and does not provide broader industry context or trends.

Related Party Transactions

• The exercise of employee stock options by Dean L. Schorno, an executive officer, constitutes a related party transaction as it involves a transaction between the company and a member of its management.

Stakeholder Impact

• Shareholders may view the increased direct ownership by a key executive as a positive signal, potentially reinforcing confidence in the company's leadership and future performance.

Key Dates

Keywords

RIGL, Rigel Pharmaceuticals, Form 4, Insider Transaction, Stock Options, Executive Compensation, Beneficial Ownership, CFO